Hottestgistnaija.com
The world’s first malaria vaccine, made by GlaxoSmithKline, is most likey going to be approved by international regulators for use in Africa from October. This was after the final trial data has showed that the vaccine has the capacity of giving a partial protection for up to four years.
The shot, called RTS,S and designed for children in Africa, would be the first licensed human vaccine against a parasitic disease and could help prevent millions of cases of malaria, which currently kills more than 600,000 people a year.
It was gathered that the Researchers at the British drugmaker GSK have been working on RTS,S for 30 years.
Advertisement
